Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Botox Resistance and Treatment Strategies

Introduction to Botox Resistance

  • Distinguish true immunologic resistance from inadequate dosing, incorrect injection technique or muscle targeting, disease progression, with inadequate dosing and incorrect injection technique being key considerations 1, 2

Condition-Specific Treatment Strategies

  • For cervical dystonia, abobotulinumtoxinA and rimabotulinumtoxinB are similarly effective and should be offered, as per the American Academy of Family Physicians 3
  • For blepharospasm, onabotulinumtoxinA and incobotulinumtoxinA are equally effective and should be considered, as per the American Academy of Family Physicians 3
  • For spasticity, abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA are all safe and effective for upper extremity spasticity, as per the American Academy of Family Physicians 3, 4
  • For neurogenic lower urinary tract dysfunction, onabotulinumtoxinA (200-300 U) strongly improves bladder storage parameters, with no difference in efficacy between 200 U and 300 U doses, as reported in The Journal of Urology 1

Minimizing Future Resistance Risk

  • Adjusting dose, distribution, and timing of injections can minimize adverse events, as per Praxis Medical Insights 2